LONDON - Fundsmith LLP, a London-based investment management firm, has decreased its holdings in Fevertree Drinks PLC (LON:FEVR), according to a notification filed with the London Stock Exchange (LON:LSEG) on Monday. The threshold was crossed on January 2, 2025, with Fundsmith LLP’s voting rights in the premium mixer company dropping from 5.08% to 4.889%.
The disclosure, mandated under the UK’s Disclosure and Transparency Rules (DTR), indicates that Fundsmith now holds a total of 5,707,107 voting rights in Fevertree Drinks, which translates to a 4.889% stake in the company. This change in shareholding is a result of an acquisition or disposal of voting rights.
The adjustment in Fundsmith’s position was completed on January 6, 2025, and reported on the same day as per regulatory requirements. The notification did not specify the reasons behind the reduction of the stake. The details of the notification show that the voting rights are held directly by Fundsmith LLP and there are no financial instruments involved that would confer additional voting rights.
Fevertree Drinks PLC, known for its high-end mixers and tonic waters, is listed on the London Stock Exchange and has a diverse product range that includes a variety of flavored tonic waters, ginger beers, and lemonades. The company has experienced significant growth since its founding, capitalizing on the rising demand for premium mixers.
The transaction may be of interest to investors monitoring the beverage sector and shareholder movements within listed companies. Shareholder compositions can influence company strategies and operations, although the immediate implications of Fundsmith’s reduced stake are not detailed in the notification.
This report is based on a press release statement and is intended to provide factual information regarding the shareholding changes in Fevertree Drinks PLC. The information provided by RNS, the news service of the London Stock Exchange, is subject to terms and conditions of use and distribution.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.